A 42-year-old woman from rural Maharashtra presents with postcoital bleeding and vaginal discharge for 3 months. She is a multipara (G5P5) with menarche at 14 years and first coitus at 18 years. On speculum examination, a friable, bleeding mass is seen on the cervix. Pap smear shows atypical squamous cells of undetermined significance (ASCUS). HPV testing is positive for HPV-16. Colposcopy-directed cervical biopsy shows invasive squamous cell carcinoma with keratin pearl formation. Which HPV-related molecular event is most directly responsible for malignant transformation in this patient?

Explanation

## Molecular Basis of HPV-Mediated Cervical Carcinogenesis ### HPV Oncogenic Mechanism **Key Point:** HPV-16 and HPV-18 (high-risk types) encode two critical oncoproteins—E6 and E7—that directly target and inactivate the two most important tumor suppressors in the cell cycle: p53 and retinoblastoma (Rb) protein. ### E6 and E7 Oncoprotein Function | Viral Protein | Target | Mechanism | Consequence | |---|---|---|---| | **E6** | p53 ("guardian of genome") | Ubiquitin-mediated proteasomal degradation | Loss of apoptosis, DNA damage checkpoint, cell cycle arrest | | **E7** | Rb protein | Binding and inactivation; prevents Rb–E2F complex formation | Uncontrolled G1/S transition; premature S-phase entry | **High-Yield:** The dual inactivation of p53 and Rb is the *primary* transforming event in HPV+ cervical cancer. This is the most direct and earliest molecular alteration. ### Sequential Events in HPV-Driven Transformation 1. **Acute infection** → HPV genome exists as episomal DNA in basal keratinocytes 2. **Persistent infection** (high-risk types) → E6/E7 expression → p53 and Rb inactivation 3. **Genomic instability** → Secondary mutations accumulate (PTEN loss, PIK3CA amplification) 4. **Integration** (optional, not always required) → Disruption of E2 gene → increased E6/E7 expression 5. **Malignant transformation** → Invasive carcinoma **Clinical Pearl:** The presence of HPV-16 (as in this patient) confers ~40× higher risk of progression to invasive cancer compared to HPV-negative cervical lesions. The positive HPV test + ASCUS + biopsy-proven invasive SCC is the classic progression pattern. ### Why This Patient Developed Cancer - **Multiparity and early coitus** → prolonged exposure to HPV and cervical trauma - **Persistent HPV-16 infection** → continuous E6/E7 expression → sustained p53/Rb inactivation - **Lack of screening** (rural setting) → lesion progressed undetected from CIN to invasive carcinoma **Mnemonic:** **E6E7-p53Rb** = The core oncogenic axis. E6 kills p53; E7 kills Rb. Both must die for cervical cancer to be born.